| Revenue | 240.19a | 179.2a |
| Cost of sales | -201.99a | -151.79a |
| Gross profit | 38.2a | 27.42a |
| Other gains/(losses), net | 0.9a | 1.37a |
| Distribution and selling expenses | -13.28a | -11.83a |
| Administrative expenses | -4.9a | -4.21a |
| Research and development expenses | -10.42a | -7.81a |
| Impairment loss on trade and other receivables | -0.13a | -0.16a |
| Impairment loss on non-financial assets, net | -0.99a | -0.32a |
| Share-based payments | -1.75a | -0.65a |
| Finance income, net | 0.69a | 0.54a |
| Share of results of associates | 0.53a | 0.37a |
| Share of results of joint ventures | 0.44a | 0.23a |
| Gain on deemed disposal of subsidiaries and provisional loss on partial disposal of a joint venture | 9.1a | 0a |
| Profit before taxation | 18.4a | 4.95a |
| Taxation | -1.6a | -0.01a |
| Profit for the year | 16.8a | 4.94a |
| Attributable to | — | — |
| Equity holders of the Company | 16.63a | 5.31a |
| Non-controlling interests | 0.17a | -0.37a |